Intravenous Immunoglobulins Alone for the Desensitization of Lung Transplant Recipients with Preformed Donor Specific Antibodies and Negative Flow Cytometry Crossmatch
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Rayid Abdulqawi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Lung Health Centre Department, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Lung Transplantation, Immunoglobulins, Intravenous, Graft Rejection, Flow Cytometry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Background
The lack of evidence regarding optimal desensitization strategies for lung transplant candidates with preformed donor specific anti‐human leukocyte antigen antibodies (DSAs) has led to varying approaches among centers towards this patient group. Our institution's desensitization protocol for recipients with preformed DSAs and negative flow cytometry crossmatch (FCXM) consists of intravenous immunoglobulin (IVIG) as the sole therapy. The study aimed to determine outcomes using this approach.
Methods
This retrospective study included adults who underwent lung‐only transplantation for the first time between January 2015 and March 2022 at a single center. We excluded patients with positive or missing FCXM results. Transplant recipients with any DSA ≥ 1000 MFI on latest testing within three months of transplant were considered DSA‐positive, while recipients with DSAs
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lung Health Centre Department, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
- College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
- Kidney and Pancreas Health Centre Department, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
- College of Medicine, King Saud University, Riyadh, Saudi Arabia.
- Chest Diseases Department, Faculty of Medicine, Baskent University, Ankara, Turkey.
- Department of Biostatistics, Epidemiology and Scientific Computing, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
ORCID-Profile: Rayid Abdulqawi, Moheeb Alawwami, Omar Aldosari, Zyad Aldosari, Mohammed Alhuqbani, Rana A Saleh, Dorina Esendagli, Haifa Aldakhil, Edward B De Vol, Khaled Alkattan, Kris Ann H Marquez, Waleed Saleh, Eid A Al-Mutairy
Zitieren
APA
Abdulqawi, R., Alawwami, M., Aldosari, O., Aldosari, Z., Alhuqbani, M., Saleh, R. A., Esendagli, D., Aldakhil, H., De Vol, E. B., Alkattan, K., Marquez, K. A. H., Saleh, W., Sandoqa, S., & Al-Mutairy, E. A. (2024). Intravenous Immunoglobulins Alone for the Desensitization of Lung Transplant Recipients with Preformed Donor Specific Antibodies and Negative Flow Cytometry Crossmatch. Clinical Transplantation. https://doi.org/10.1111/ctr.15374
Vancouver
Abdulqawi R, Alawwami M, Aldosari O, Aldosari Z, Alhuqbani M, Saleh RA, et al. Intravenous Immunoglobulins Alone for the Desensitization of Lung Transplant Recipients with Preformed Donor Specific Antibodies and Negative Flow Cytometry Crossmatch. Clinical Transplantation. 2024. doi:10.1111/ctr.15374
BibTeX
@article{Abdulqawi2024,
author = {Abdulqawi, Rayid and Alawwami, Moheeb and Aldosari, Omar and Aldosari, Zyad and Alhuqbani, Mohammed and Saleh, Rana A and Esendagli, Dorina and Aldakhil, Haifa and De Vol, Edward B and Alkattan, Khaled and Marquez, Kris Ann H and Saleh, Waleed and Sandoqa, Sahar and Al-Mutairy, Eid A},
title = {Intravenous Immunoglobulins Alone for the Desensitization of Lung Transplant Recipients with Preformed Donor Specific Antibodies and Negative Flow Cytometry Crossmatch},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15374}
}
EUVIMED